{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:54Z","timestamp":1790675394013,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103446","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T17:10:19Z","timestamp":1407172219000},"page":"e103446","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictors of HVTN 503 MRK-AD5 HIV-1 gag\/pol\/nef Vaccine Induced Immune Responses"],"prefix":"10.1371","volume":"9","author":[{"given":"Kathryn L.","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"DeRosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maphoshane","family":"Nchabeleng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koleka","family":"Mlisana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case\u2013cohort analysis","volume":"372","author":"JM McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel Adenovirus Vector-Based Vaccines for HIV-1","volume":"5","author":"DH Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11(7)","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref4","first-page":"168","article-title":"Where are we going with HIV vaccines? S Afr J Sci","volume":"105","author":"L Morris","year":"2009"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-540-71029-5_13","article-title":"Use of adenovirus in vaccines for HIV","volume":"(188)","author":"S Patterson","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"FH Priddy","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector","volume":"194","author":"AT Catanzaro","year":"2006","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1128\/JVI.01041-08","article-title":"Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute\/early HIV-1 infection","volume":"82","author":"ZL Brumme","year":"2008","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","article-title":"Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals","volume":"75","author":"JJ Goronzy","year":"2001","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.vaccine.2011.08.011","article-title":"Effectiveness and safety of influenza vaccination in children: European perspective","volume":"29","author":"T Helkkinen","year":"2011","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live Attenuated vs inactivated influenza vaccine in infants and young children","volume":"356","author":"RB Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine","volume":"254","author":"DJ Weber","year":"1985","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.vaccine.2009.10.125","article-title":"Hepatitis B vaccination strategies tailored to different endemicity levels: Some considerations","volume":"28","author":"NY Rots","year":"2010","journal-title":"Vaccine"},{"key":"ref15","article-title":"Recombinant adenovirus type 5 HIV gag\/pol\/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503\/Phambili study","author":"GE Gray","year":"2014","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00002030-200108004-00011","article-title":"The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations","volume":"15","author":"HA Weiss","year":"2001","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.926","article-title":"Vaccine-Induced HIV Seropositivity\/Reactivity in Noninfected HIV Vaccine Recipients","volume":"304(3)","author":"CJ Cooper","year":"2010","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/428450","article-title":"Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from four continents","volume":"Dis","author":"PM Coplan","year":"2005","journal-title":"J Infect"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/COH.0b013e32833d2d2b","article-title":"Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag\/pol\/nef subtype B HIV vaccine","volume":"5","author":"GE Gray","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","volume":"122","author":"N Frahm","year":"2012","journal-title":"J Clin Invest"},{"key":"ref22","first-page":"257","article-title":"Influence of alcohol and gender on immune response","volume":"26","author":"EJ Kovacs","year":"2002","journal-title":"Alcohol Res Health"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0022-4731(89)90088-5","article-title":"Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis","volume":"34","author":"CJ Grossman","year":"1989","journal-title":"J Steroid Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1126\/science.7638587","article-title":"Zeroing in on how hormones affect the immune system","volume":"269","author":"V Morell","year":"1995","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T Cell proliferation","volume":"26","author":"V De Rosa","year":"2007","journal-title":"Immunity"},{"key":"ref26","first-page":"137","article-title":"Alcohol, injury and cellular immunity","volume":"28","author":"KAN Messingham","year":"2002","journal-title":"Alcohol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri744","article-title":"Alcohol, host defence and society","volume":"2","author":"S Nelson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0891-5849(01)00745-6","article-title":"Free radicals, chemokines, and cell injury in HIV\u20131 and SIV infections and alcoholic hepatitis","volume":"31","author":"AP Bautista","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.physbeh.2003.12.017","article-title":"Dose-dependent effects of alcohol on appetite and food intake","volume":"81(1)","author":"SJ Caton","year":"2004","journal-title":"Physiol Behav"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2006.04.016","article-title":"Hepatitis A\/B vaccination of adults over 40 years old: Comparison of three vaccine regimens and effect of influencing factors","volume":"24(26)","author":"M Van der Wielen","year":"2006","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ageing\/28.2.141","article-title":"Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care","volume":"28(2)","author":"JM Potter","year":"1999","journal-title":"Age and ageing"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/S0264-410X(03)00041-0","article-title":"Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms","volume":"21(19)","author":"VE Burns","year":"2003","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/70.5.928","article-title":"De novo lipogenesis, lipid kinetics and whole-body lipid balances in humans after acute alcohol consumption","volume":"70","author":"SQ Siler","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-\u03b1 knockout mice","volume":"97","author":"PA Heine","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/QAI.0b013e3181adcbbe","article-title":"The potential role of biomarkers in HIV preventive vaccine trials: a critical review","volume":"51","author":"E MacLachlan","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1467-789x.2001.00025.x","article-title":"Obesity and immune function relationships","volume":"2","author":"A Marti","year":"2001","journal-title":"Obes Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"01","DOI":"10.4102\/sajs.v107i3\/4.650","article-title":"Fatter and fatter: South Africa's rise in body mass index","volume":"107","author":"AG Morris","year":"2011","journal-title":"S Afr J Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:23:08Z","timestamp":1588965788000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103446"}},"subtitle":[],"editor":[{"given":"Eric A.","family":"Weaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103446","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]}}}